ON THE ROLE OF C1-INHIBITOR AS INHIBITOR OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR

被引：0

作者：

HUISMAN, LGM

VANGRIENSVEN, J

KLUFT, C

机构：

[1] TNO,IVVO,GAUBIUS LAB,2313 AD LEIDEN,NETHERLANDS

[2] CTR HUMAN DRUG RES,LEIDEN,NETHERLANDS

来源：

THROMBOSIS AND HAEMOSTASIS | 1993年 / 69卷 / 06期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1269 / 1269

页数：1

共 50 条

[21] THE EFFECT OF THE RELATIONSHIP BETWEEN TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 ON TISSUE-TYPE PLASMINOGEN-ACTIVATOR ACTIVITY IN INSULIN-DEPENDENT DIABETES-MELLITUS
MYRUP, B
ROSSING, P
JENSEN, T
GRAM, J
KLUFT, C
JESPERSEN, J
FIBRINOLYSIS, 1994, 8 : 22 - 24
[22] TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND TISSUE-TYPE PLASMINOGEN ACTIVATOR-PLASMINOGEN ACTIVATOR INHIBITOR TYPE-1 COMPLEX ARE RECOGNIZED BY DIFFERENT RECEPTOR SYSTEMS IN THE LIVER
KUIPER, J
OTTER, M
VANZONNEVELD, AJ
RIJKEN, DC
VANBERKEL, TJC
CIRCULATION, 1993, 88 (04) : 366 - 366
[23] BIOLOGICAL EFFECTS OF INACTIVATION OF THE GENES FOR TISSUE-TYPE PLASMINOGEN-ACTIVATOR, UROKINASE-TYPE PLASMINOGEN-ACTIVATOR AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 IN MICE
CARMELIET, P
SCHOONJANS, L
KIECKENS, L
STASSEN, JM
BRONSON, R
COLLEN, D
MULLIGAN, R
FIBRINOLYSIS, 1993, 7 : 27 - 28
[24] BIOLOGICAL EFFECTS OF DISRUPTION OF THE TISSUE-TYPE PLASMINOGEN-ACTIVATOR, UROKINASE-TYPE PLASMINOGEN-ACTIVATOR, AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 GENES IN MICE
CARMELIET, P
BOUCHE, A
DECLERCQ, C
JANSSEN, S
POLLEFEYT, S
WYNS, S
MULLIGAN, RC
COLLEN, D
ATHEROSCLEROSIS III: RECENT ADVANCES IN ATHEROSCLEROSIS RESEARCH: THE THIRD SARATOGA INTERNATIONAL CONFERENCE ON ATHEROSCLEROSIS IN NEKOMA, 1995, 748 : 367 - 382
[25] TYPE-1 PLASMINOGEN-ACTIVATOR INHIBITOR AND TISSUE-TYPE PLASMINOGEN-ACTIVATOR IN CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL) LYMPHOCYTES
ANKRI, A
MENTZ, F
CHEVRET, S
COUTY, MC
BINET, JL
BLOOD, 1994, 84 (10) : A459 - A459
[26] TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 IN NORMAL AND ENDOTOXIN-TREATED RAT AORTA
QUAX, PHA
PADRO, T
EMEIS, JJ
VANDENHOOGEN, RM
VERHEIJEN, JH
THROMBOSIS AND HAEMOSTASIS, 1991, 65 (06) : 834 - 834
[27] TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND PLASMINOGEN-ACTIVATOR INHIBITOR ACTIVITIES AS PREDICTORS OF ADVERSE EVENTS IN UNSTABLE ANGINA
WIECZOREK, I
LUDLAM, CA
FOX, KAA
AMERICAN JOURNAL OF CARDIOLOGY, 1994, 74 (05): : 424 - 429
[28] TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 AFTER EXERCISE - COMPARISON TO VENOUS OCCLUSION AND DDAVP
VENE, N
STEGNAR, M
FIBRINOLYSIS, 1990, 4 : 105 - 107
[29] THE SIGNIFICANCE OF FIBRIN BINDING BY PLASMINOGEN-ACTIVATOR INHIBITOR-1 FOR THE MECHANISM OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR MEDIATED FIBRINOLYSIS
STRINGER, HAR
PANNEKOEK, H
THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 1004 - 1004
[30] AGE-RELATED-CHANGES IN THE BASAL LEVEL OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND PLASMINOGEN-ACTIVATOR INHIBITOR-1
STEGNAR, M
PENTEK, M
FIBRINOLYSIS, 1992, 6 : 55 - 57

← 1 2 3 4 5 →